Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

Inflazyme granted Australian patent for antiinflammatory agents

June 9, 1997

Aciclovir demonstrates antiasthmatic activity in animal model

June 9, 1997

Clinical trials for Albuterol Spiros completed

June 6, 1997

Potent LT biosynthesis inhibitors described by Abbott

June 6, 1997

Dual H1 and CysLT1 antagonist reported by Dutch and Japanese researchers

June 4, 1997

PPL Therapeutics reports positive phase I results for AAT

June 3, 1997

Antiallergic/antiasthmatic agents from Sumitomo Metal

June 2, 1997

T Cell Sciences completes patient enrollment for reperfusion injury trial

June 2, 1997

Positive preclinical results for Inflazyme's Apanol

June 2, 1997

U.K. introduction for Nasonex

May 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...